top of page
Invclicosta post 8.png

Ethics Committeein Research

CEI is an independent organization, among its functions it will review in a timely manner the ethical and methodological principles and compliance with:

  • Resolution 8430 of 1993

  • Resolution 2378 of 2008

  • Mandatory INVIMA compliance guides

  • CEI's own standards

  • Helsinki Declaration

  • International Guidelines for Good Clinical Practice


Our Objective

Evaluate the risks and benefits of clinical research, promoting ethics and integrity inherent to the human being in accordance with constitutional and legal principles and values, safeguarding the rights of participants during a Clinical Trial.

The Research Ethics Committee evaluates the following clinical trials:

  • Phase I

  • Phase IIA

  • Phase IIB

  • Phase IIIA

  • Phase IIIB

  • Phase IV (with intervention)

  • Observational studies

  • Biobank

  • University undergraduate and postgraduate research projects (Inter-institutional Agreement)

  • Research carried out by the IPS Clínica de la Costa SAS, in special agreement with the Simón Bolívar University.

Invclicosta post 8 (1).png

What kind of research do we evaluate?

Invclicosta post 8 (2).png

Principles and Ethical Framework

The Ethical Principles are accepted to carry out research with subjects, whether established by national and international guidelines of: Good Clinical Practices (GCP).

The Ethical Framework must be based on the principles contemplated:

  • Nuremberg Code of Ethics (1946)

  • Declaration of Helsinki (1964)

  • Belmont Report (1976-79)

  • International Ethical Guidelines for Biomedical Research Involving Human Beings (CIOMS 2017)

  • World Health Organization (WHO)


of the Ethics Committee




Ethics Committee 

in Research

Office: Carrera 50 # 80 -144, Piso 2

Telephone: (605) 336 99 99 EXT. 209

Invclicosta post 8 (3).png
bottom of page